Follow
Naveen Krishnegowda, MD
Naveen Krishnegowda, MD
Research Scholar
Verified email at uthscsa.edu - Homepage
Title
Cited by
Cited by
Year
Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer
FS Hogan, NK Krishnegowda, M Mikhailova, MS Kahlenberg
Journal of Surgical Research 143 (1), 58-65, 2007
2522007
Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation
R Bedolla, TJ Prihoda, JI Kreisberg, SN Malik, NK Krishnegowda, ...
Clinical cancer research 13 (13), 3860-3867, 2007
1672007
Effect of adipose tissue-derived osteogenic and endothelial cells on bone allograft osteogenesis and vascularization in critical-sized calvarial defects
A Cornejo, DE Sahar, SM Stephenson, S Chang, S Nguyen, T Guda, ...
Tissue Engineering Part A 18 (15-16), 1552-1561, 2012
602012
Immunologic parameters during NOTES compared with laparoscopy in a randomized blinded porcine trial
J Bingener, NK Krishnegowda, JE Michalek
Surgical endoscopy 23, 178-181, 2009
472009
Knockdown of prothrombin in zebrafish
K Day, N Krishnegowda, P Jagadeeswaran
Blood Cells, Molecules, and Diseases 32 (1), 191-198, 2004
472004
Novel function of transcription factor Nrf2 as an inhibitor of RON tyrosine kinase receptor-mediated cancer cell invasion
A Thangasamy, J Rogge, NK Krishnegowda, JW Freeman, ...
Journal of Biological Chemistry 286 (37), 32115-32122, 2011
402011
Effect of endothelial differentiated adipose-derived stem cells on vascularity and osteogenesis in poly (D, L-lactide) scaffolds in vivo
DE Sahar, JA Walker, HT Wang, SM Stephenson, AR Shah, ...
Journal of craniofacial surgery 23 (3), 913-918, 2012
262012
Gossypin as a novel selective dual inhibitor of V-RAF murine sarcoma viral oncogene homolog B1 and cyclin-dependent kinase 4 for melanoma
S Bhaskaran, KV Dileep, SS Deepa, C Sadasivan, M Klausner, ...
Molecular cancer therapeutics 12 (4), 361-372, 2013
232013
Differentiated adipose-derived stem cell cocultures for bone regeneration in polymer scaffolds in vivo
AR Shah, A Cornejo, T Guda, DE Sahar, SM Stephenson, S Chang, ...
Journal of Craniofacial Surgery 25 (4), 1504-1509, 2014
202014
Impaired development of early endometriotic lesions in CD44 knockout mice
JF Knudtson, RR Tekmal, MT Santos, PA Binkley, N Krishnegowda, ...
Reproductive Sciences 23 (1), 87-91, 2016
162016
Synergistic Effect Between Curcumin (diferuloylmethane) and Radiation on Clonogenic Cell Death Independent of p53 in Prostate Cancer Cells. J Cancer Sci Ther 2: 171-181. doi …
BK Nayak, NK Krishnegowda, CA Galindo, ML Meltz, GP Swanson
OMICS Publishing Group J Cancer Sci Ther ISSN 5956, 171-181, 1948
161948
Compensatory increases in Her-2/neu activation in response to EGFR tyrosine kinase inhibition in colon cancer cell lines
PA Learn, N Krishnegowda, J Talamantez, MS Kahlenberg
Journal of Surgical Research 136 (2), 227-231, 2006
152006
Therapeutic use of estrogen receptor β agonists in prevention and treatment of endocrine therapy resistant breast cancers: observations from preclinical models
K Ramasamy, C Samayoa, N Krishnegowda, RR Tekmal
Progress in Molecular Biology and Translational Science 151, 177-194, 2017
142017
Raf-1, a potential therapeutic target, mediates early steps in endometriosis lesion development by endometrial epithelial and stromal cells
EM De La Garza, PA Binkley, M Ganapathy, NK Krishnegowda, ...
Endocrinology 153 (8), 3911-3921, 2012
112012
Estrogen receptor-beta mediates the protective effects of aromatase induction in the MMTV-Her-2/neu x aromatase double transgenic mice
HB Nair, RP Perla, NB Kirma, NK Krishnegowda, M Ganapathy, ...
Hormones and Cancer 3, 26-36, 2012
102012
Clinical and pathologic features of hispanic endometrial cancer patients with loss of mismatch repair expression
ER Kost, PT Valente, BA Lynch, NK Krishnegowda, AM Hertz, KL Hall, ...
International Journal of Gynecologic Cancer 26 (6), 2016
82016
Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo
HB Nair, B Santhamma, NK Krishnegowda, KV Dileep, KJ Nickisch
PloS one 11 (3), e0151182, 2016
72016
The estrogen receptor β agonists, Liquiritigenin and S-equol, inhibit breast cancer cell proliferation through the activation of tumor-suppressor and other pathways.
C Samayoa, A Kotha, NK Krishnegowda, RK Vadlamudi, RR Tekmal
Cancer Research 73 (8_Supplement), 1312-1312, 2013
22013
Novel role of PARP4 in hormone-dependent breast cancer progression and metastasis
HBB Nair, N Krishnegowda, B Nair, M Ganapathy, O S, N Kirma, ...
Cancer Research 70 (8_Supplement), 4607-4607, 2010
22010
Potential therapeutic use of Estrogen Receptor β agonist in the prevention and progression of breast cancer using HER-2/neu mouse model
K Ramasamy, C Samayoa, NK Krishnegowda, RK Vadlamudi, RR Tekmal
Cancer Research 77 (13_Supplement), 3616-3616, 2017
12017
The system can't perform the operation now. Try again later.
Articles 1–20